meglumine and Renal Insufficiency

meglumine has been researched along with Renal Insufficiency in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (11.76)	18.2507
2000's	10 (58.82)	29.6817
2010's	5 (29.41)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flynn, MM; Lipowska, AM; Parekh, AN; Parikh, MR; Perez, SD; Runge, TM; Sakaria, SS; Shaffer, KM; Sood, A; Subramanian, RM	1
Parikh, MR; Perez, SD; Runge, TM; Sakaria, SS; Shaffer, KM; Subramanian, RM	1
Cox, KL; Moreno, CC; Nandwana, SB; Osipow, MT; Sekhar, A	1
Bruce, R; Djamali, A; Garrett, RW; Haemel, AK; Sadowski, DR; Sadowski, EA; Wentland, AL	1
Broome, DR; Bryant, BJ; Im, K	1
Bóia, MN; Brustoloni, YM; Cunha, RV; Dorval, ME; Fernandes, TD; Oliveira, AL	1
Abujudeh, HH; Agarwal, S; Gebreananya, ZA; Kaewlai, R; Kay, J; Rolls, H; Saini, S; Schaefer, PW	1
Balasegaram, M; Hailu, A; Hailu, W; Hurissa, Z; Omollo, R; Tafes, H; Weldegebreal, T; Yifru, S	1
Bennett, LK; Chan, MR; Djamali, A; Garrett, AL; Garrett, RW; Sadowski, EA; Wentland, AL	1
Abu-Alfa, A; Saab, G	1
Broome, DR; Kanal, E; Martin, DR; Thomsen, HS	1
Clément, O	1
Endo, K; Takahashi-Taketomi, A; Tsushima, Y	1
Buffet, P; Deray, G; Grögl, M; Jacobs, C; Martinez, F	1
Bensel, K; Davies, BE; LaFrance, ND; Lambrecht, LJ; McCloud, S; Parker, JR; Swan, SK; Townsend, R	1
Hantson, P; Haufroid, V; Lambert, M; Luyasu, S	1
Bensel, K; Cohen, DL; Davies, BE; Katholi, R; Lambrecht, L; Parker, J; Swan, SK; Townsend, RR	1

Trials

2 trial(s) available for meglumine and Renal Insufficiency

Article	Year
Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Investigative radiology, 1999, Volume: 34, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Safety; Spectrophotometry, Atomic	1999
Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:6 Topics: Contrast Media; Double-Blind Method; Gadolinium; Humans; Infusions, Intravenous; Meglumine; Organometallic Compounds; Renal Insufficiency	2000

Article

Year

Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment.

Investigative radiology, 1999, Volume: 34, Issue:7

Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Safety; Spectrophotometry, Atomic

1999

Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:6

Topics: Contrast Media; Double-Blind Method; Gadolinium; Humans; Infusions, Intravenous; Meglumine; Organometallic Compounds; Renal Insufficiency

2000

Other Studies

15 other study(ies) available for meglumine and Renal Insufficiency

Article	Year
Renal Safety of Intravenous Gadolinium-enhanced MRI in Patients Following Liver Transplantation. Transplantation, 2019, Volume: 103, Issue:6 Topics: Acute Kidney Injury; Administration, Intravenous; Adult; Aged; Biomarkers; Contrast Media; Creatinine; Female; Georgia; Humans; Incidence; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Postoperative Complications; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors	2019
Renal safety of intravenous gadolinium-enhanced magnetic resonance imaging in patients awaiting liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2015, Volume: 21, Issue:11 Topics: Contrast Media; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gadolinium; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Reproducibility of Results; Retrospective Studies; Watchful Waiting	2015
Gadobenate Dimeglumine Administration and Nephrogenic Systemic Fibrosis: Is There a Real Risk in Patients with Impaired Renal Function? Radiology, 2015, Volume: 276, Issue:3 Topics: Adolescent; Adult; Aged; Contrast Media; Female; Humans; Incidence; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Insufficiency; Retrospective Studies; Risk Assessment; Young Adult	2015
Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide. Investigative radiology, 2016, Volume: 51, Issue:11 Topics: Comorbidity; Contrast Media; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Image Enhancement; Incidence; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors	2016
Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI. Clinical radiology, 2009, Volume: 64, Issue:7 Topics: Adult; Aged; Aged, 80 and over; California; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Incidence; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Prospective Studies; Renal Insufficiency	2009
Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil. Tropical doctor, 2009, Volume: 39, Issue:3 Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Heart; Humans; Leishmaniasis, Visceral; Liver Failure; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Renal Insufficiency	2009
Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients. Journal of magnetic resonance imaging : JMRI, 2009, Volume: 30, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Comorbidity; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Massachusetts; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Prevalence; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors	2009
Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2010, Volume: 104, Issue:11 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Comorbidity; Ethiopia; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Renal Insufficiency; Treatment Outcome; Young Adult	2010
Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology, 2007, Volume: 243, Issue:1 Topics: Adolescent; Adult; Aged; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Retrospective Studies; Risk Factors; Skin; Skin Diseases	2007
Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis? Radiology, 2007, Volume: 244, Issue:3 Topics: Adolescent; Adult; Aged; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Risk Factors; Skin; Skin Diseases	2007
Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology, 2008, Volume: 246, Issue:1 Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Renal Insufficiency; Risk; United States; United States Food and Drug Administration	2008
[The Grenelle of MR contrast agents?]. Journal de radiologie, 2007, Volume: 88, Issue:11 Pt 1 Topics: Contrast Media; Europe; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Product Surveillance, Postmarketing; Renal Insufficiency; United States; United States Food and Drug Administration	2007
Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible. Radiology, 2008, Volume: 247, Issue:3 Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Renal Insufficiency; Risk; Risk Factors	2008
Tolerance and pharmacokinetics of antimony in a patient with renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:8 Topics: Antiprotozoal Agents; Female; Humans; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Renal Insufficiency	1995
Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy. Pharmacotherapy, 2000, Volume: 20, Issue:9 Topics: Antimony; Antiprotozoal Agents; Creatinine; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Oliguria; Organometallic Compounds; Renal Insufficiency; Shock, Septic	2000